drugset / Trial / NCT00659802
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of HMPL-004 in patients with active mild to moderate ulcerative colitis (UC), compared with placebo.
Timeline
- Start
- 2008-02-07
- Primary completion
- 2009-10-13
- Completion
- 2009-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | andrographolide | Small molecule | 400 mg | Oral |
| Subject | andrographolide | Small molecule | 600 mg | Oral |